Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Myelodysplastic disease
Age: Adult
Dose: Oral – 10 mg
Frequency: once daily
Duration: for 21 consecutive days of repeated 28-day cycle
Indication: Multiple myeloma
Age: Adult
Condition: In combination with dexamethasone
Dose: Oral – Lenalidomide: 25 mg
Frequency: once daily
Duration: for 21 consecutive days of repeated 28-day cycle

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Tablet – No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Indication: Myelodysplastic disease
Condition: Moderate renal impairment
Dose: Tablet – 5 mg
Frequency: once daily
Indication: Myelodysplastic disease
Condition: Severe renal impairment (not requiring dialysis)
Dose: Tablet – 5 mg
Frequency: every other day
Administration
  • Take at the same time every day
  • Swallow whole with water
Side Effect

Drug Interaction

Drug NameRisk Factors
Erythropoietic agents
May increase risk of thrombosis
Digoxin, ketoconazole, itraconazole, ciclosporin, verapamil, quinidine, clarithromycin
May increase plasma concentration

Disease Interaction

Disease NameRisk Factors
Women of Childbearing Age Without Contraception
Risk of birth defects
Drug Hypersensitivity
Risk of severe reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C in a dry place. Protect from light. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.